Manufacturers

The essential guide to drug commercialization

Manufacturers

Acceleration of innovation in healthcare delivery

Manufacturers

The time is right for commercializing prescription digital therapeutics

Closing the Gaps in Pre-Approval Information Exchange to Accelerate Product Success and Patient Access

Manufacturers

Differentiate your product with FormularyDecisions®

HTA Quarterly | Winter 2021

Is NICE becoming nicer?

Evidence generation and approval of digital health applications in Germany

Telehealth through the lens of value-based care in the US

Health disparities and health technology assessment: Current value assessment frameworks fall short

Gaining real-world oncology insights from engagement of key opinion leaders through virtual and live solutions

Equity considerations in US value assessment: Opportunities ahead

Manufacturers

Navigating the payer landscape for digital therapeutics

Update: The impact of obesity on COVID-19 outcomes of hospitalizations and mortality

Manufacturers

Work worth doing: FormularyDecisions

HTA Quarterly | Summer 2021

Manufacturers

Ebook: Strategic partnerships for unlocking product potential

The impact of obesity on COVID-19 outcomes of hospitalizations and mortality

Patient forward: comparing ICER and PCORI use of patient feedback

Manufacturers

Is your PIE incomplete?

Webinar: 5 Years of ICER - Insights and Impact on Payers

Case study: Gaining payer attention through digital innovation

Manufacturers

The Future of Payer Engagement: How Pharma Can Break Through

Manufacturers

Mind the (Evidence) Gap

Effectively Communicating Pipeline Information to Drive Payers Attention

Manufacturers

How Digital Innovation Drives Improved Market Access Strategies

Responding to Stakeholder Input: Finding the Patient Voice in ICER's Value Assessments